Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX
Bumpus Namandje sold 3,963 Recursion Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 17 to Jun 18, 2026 · Filed Jun 22, 2026
From Jun 17 to Jun 18, 2026, Bumpus Namandje (Director) sold 3,963 Recursion Pharmaceuticals, Inc. shares at US$3.18 for US$12,602 under a trading plan, leaving 127,632 shares. Filed Jun 22, 2026 (Form 4).
- Sold
- 3,963 shares
- Price
- US$3.18
- Value
- US$12,602
- Holding after
- 127,632 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Class A Common Stock | Award | 88,424 | 131,595 | Direct | |
| Jun 18, 2026 | Class A Common Stock | Sale | 3,963 | US$3.18 | 127,632 | Direct |
Source
Related
- Recursion Pharmaceuticals, Inc.
- Bumpus Namandje
- Recursion Pharmaceuticals, Inc. shareholders
- Form 4 · Bumpus Namandje · Jun 4, 2026
- Form 4 · Borgeson Blake · Oct 7, 2026
- Form 4 · Hershberg Robert · Oct 7, 2026
- Form 4 · Dar Zavain · Oct 2, 2026
- Form 4 · Li Dean Y · Oct 2, 2026
- Form 4 · Taylor Ben R · Sep 16, 2026